Team - Allinky Biopharma

Miguel Vega, M.Eng & PDD-IESE
CEO to Allinky Biopharma.
From 2003 to 2011, Miguel Vega served as Director for Studies & Innovation, as well as Head of Tech Transfer Unit, at Genoma España (Spanish National Foundation for Genomics and Biotechnology). During this period he had an active participation and co-leadership of one of the largest Public Biotechnology Seed Capital Funds in Spain. Before 2003, he held different positions for more than six years as Director for Entrepreneurship and Business Development at Madrid Science Park; Head of the Biotechnology Innovation Program at Madri+d (Madrid Regional Platform for Science and Technology); and Scientific Agent and grantholder at IPTS (European Commission, Joint Research Center). He holds a Degree in Agro-Food Engineering (equivalent to U.S. B.Sc. and M. Eng. in Bioprocess) from the Universidad Politécnica de Madrid and a Diploma from The Programme for Management Development (PDD)-IESE Business School.

Esther Carrasco, Ph.D.
Head of Medicinal Chemistry, Allinky Biopharma
Esther Carrasco holds a Degree in Chemistry by the University of Extremadura (Spain) where she also carried out her Ph.D. Thesis in Carbohydrate Chemistry. In 2008 she joined the Institute of Advanced Chemistry of Catalonia belonging to the Spanish National Research Council under the coordination of Professor Angel Messeguer. For the past 4 years she has been involved in many medicinal chemistry projects for lead optimization of different molecules targeting novel routes in inflammation and immunology related diseases.

Pedro Campos, Ph.D.
Head of Molecular and Cell Biology, Allinky Biopharma.
Pedro Campos has more than 7 years of research experience in the discovery and development of allosteric modulators of MAP Kinases. He has been actively involved in the setting of novel technology platforms for allosteric compound identification and validation. Dr. Campos is a Chemical Biologist by training (Universidad Autónoma de Madrid) and has obtained his Ph.D. degree from the “Severo Ochoa” Center for Molecular Biology (CBM-CSIC).

Patricia Gómez, Ph.D.
Head of Computational Chemistry, Allinky Biopharma.
Patricia Gómez has more than 7 years of research experience in the discovery and development of allosteric modulators of GPCR and MAP Kinases. She has been actively involved in in silico design of allosteric compounds that are currently under regulatory preclinical and clinical studies. Dr. Gómez is a Chemist by training (Universidad de Barcelona) and has obtained his Ph.D. degree from Polytechnic University of Catalonia.

Asunción Burguete, Ph.D.
Medicinal Chemistry Department, Allinky Biopharma
Asunción Burguete holds a Degree in Chemistry by the University of Navarra (Spain) where she also carried out her Ph.D. Thesis in Medicinal Chemistry. In 2009 she joined the Institute of Advanced Chemistry of Catalonia belonging to the Spanish National Research Council under the coordination of Professor Angel Messeguer. For the past 3 years she has been involved in different medicinal chemistry projects for lead optimization and synthesis.